Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: 148 Reexam Terminated.

<What makes you so sure that Moore is referring to money already owed to him >

From Moore's complaint. Third cause of action, as to all defendants.

"That attorney Leckrone and TPL be directed to pay to plaintiff 55% of license fees received for licenses of the MMP portfolio written by TPL and/or Alliacense, after dedcution of the reasonable, legitimate and appropriate expenses of such licensing activity."

The underlined are past tense. It is also a number that is known. The amount sought here is easily 50 million. IMO, Moore is assuming Leckrone does not have 50 million cash on hand and therefore such payment would come from future licesening activity.

Lastly, Moore is not requesting any monetary payment from Leckrone/TPL regarding future MMP licensing. I suspect Moore assumes that the only way he receives compensation for the past is if certain agreements are nullified by the court. If nullified, Moore is the receipient of 50% of license fee, unless some new agreement is adopted with TPL or some other entity.

All IMO,

Opty

Share
New Message
Please login to post a reply